1963
DOI: 10.1136/bmj.1.5336.979
|View full text |Cite
|
Sign up to set email alerts
|

Further Experimental Studies on the Prevention of Rh Haemolytic Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
59
0

Year Published

1967
1967
2012
2012

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 221 publications
(61 citation statements)
references
References 5 publications
2
59
0
Order By: Relevance
“…Two lines of research support this view. First, Ag-specific IgM, passively administered to mice or humans together with Ag can enhance the Ab response to the Ag via Ab feedback regulation (31)(32)(33)(34)(35). This enhancement depends on the ability of IgM to activate C (34,35).…”
Section: Igm Mutation | Natural Igmmentioning
confidence: 99%
“…Two lines of research support this view. First, Ag-specific IgM, passively administered to mice or humans together with Ag can enhance the Ab response to the Ag via Ab feedback regulation (31)(32)(33)(34)(35). This enhancement depends on the ability of IgM to activate C (34,35).…”
Section: Igm Mutation | Natural Igmmentioning
confidence: 99%
“…A well-known example of this is the ability of IgG to completely suppress the response to large particulate Ags like erythrocytes (2). The suppressive capacity of IgG is used successfully in the clinic to prevent rhesus D-negative women from becoming immunized against fetal rhesus D-positive erythrocytes transferred via transplacental hemorrhage (3,4). IgG Abs have dual roles in feedback regulation and can also enhance Ab responses.…”
mentioning
confidence: 99%
“…The inhibitory receptor for IgG, Fc␥RIIB, exerts a negative influence on enhancement mediated by IgG1, IgG2a, or IgG2b as demonstrated by the "superenhancement" caused by these isotypes in mice lacking Fc␥RIIB (7,9). IgG enhances not only primary Ab responses, but also secondary Ab responses (10,11), the formation of germinal centers (GCs) 3 (9,12), somatic hypermutation (13), and proliferation of specific CD4 ϩ T cells (9).…”
mentioning
confidence: 99%
“…A major breakthrough in the management of HDN was the use of passively administered anti-D described by Sir Cyril Clarke in 1963, to prevent anti-Rh D sensitisation (Clarke et al, 1963). The inspiration for this work was the observation that in Rh D incompatible pregnancies where there was also ABO mismatch, any Rh D positive red cells crossing the placenta into the maternal circulation would be rapidly cleared before Rh D sensitisation could occur.…”
Section: Contribution To Haematology and Transfusion Medicinementioning
confidence: 99%